DERMFREE ORIGINAL NASAL
Approved
Approval ID
3432c4a6-3e48-db91-e063-6394a90a28ee
Product Type
HUMAN OTC DRUG LABEL
Effective Date
May 2, 2025
Manufacturers
FDA
Jiangxi Yudexi Pharmaceutical Co., LTD
DUNS: 455662836
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Naphazoline HCL 0.05% ORIGINAL NASAL
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code85248-006
Application NumberM012
Product Classification
M
Marketing Category
C200263
G
Generic Name
Naphazoline HCL 0.05% ORIGINAL NASAL
Product Specifications
Route of AdministrationNASAL
Effective DateMay 2, 2025
FDA Product Classification
INGREDIENTS (5)
BORNEOLInactive
Code: M89NIB437X
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
NAPHAZOLINE HCLActive
Quantity: 0.05 g in 100 mL
Code: MZ1131787D
Classification: ACTIB
CAMPHOR (SYNTHETIC)Inactive
Code: 5TJD82A1ET
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT